YDR271C Antibody

Shipped with Ice Packs
In Stock

Description

Overview of YDR271C Antibody

The YDR271C antibody is a polyclonal antibody targeting the protein product of the YDR271C gene in Saccharomyces cerevisiae (Baker’s yeast). This gene is classified as a "dubious open reading frame" (ORF), meaning its functional relevance remains unconfirmed, though it has been implicated in protein interaction studies . The antibody is primarily used in research settings to investigate yeast genetics and proteomics.

Target Protein Characteristics

The YDR271C gene encodes a hypothetical protein (UniProt ID: P87282) with no well-characterized functional domains. Key features include:

PropertyDetails
OrganismSaccharomyces cerevisiae (strain ATCC 204508 / S288c)
Gene TypeDubious ORF
Protein Length100 amino acids (predicted)
Molecular Weight~11 kDa
Antibody HostNot specified (polyclonal, likely raised in rabbits or similar model systems)
ApplicationsWestern blot, immunoprecipitation (based on supplier documentation)

Protein Interaction Studies

YDR271C was identified as a potential interactor of the mucin-type glycoprotein Msb2p in S. cerevisiae using protein microarrays . Though its role in this interaction remains unvalidated, the YDR271C antibody has been employed in preliminary assays to explore its localization and binding partners.

Chromatin Immunoprecipitation (ChIP)

In a study analyzing histone H2A.Z (Htz1p) association with promoters, YDR271C was listed as a control target in ChIP experiments using an anti-Htz1 antibody . While YDR271C itself is not a histone-related gene, its inclusion suggests its use as a negative or technical control in genomic assays.

Challenges and Limitations

  • Dubious ORF Status: The lack of confirmed biological function for YDR271C limits the antibody’s utility in hypothesis-driven research .

  • Validation Gaps: As with many antibodies targeting uncharacterized proteins, reliability depends heavily on context-specific validation .

  • Niche Use Case: Primarily restricted to yeast proteomics studies, with no documented applications in therapeutic or industrial settings .

Future Directions

Further studies could clarify YDR271C’s role in yeast biology, leveraging CRISPR-based knockout models paired with this antibody to assess phenotypic or molecular changes. Improved validation protocols, such as mass spectrometry or orthogonal assays, would enhance confidence in its specificity .

Product Specs

Buffer
**Preservative:** 0.03% Proclin 300
**Constituents:** 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
YDR271CPutative uncharacterized protein YDR271C antibody
Target Names
YDR271C
Uniprot No.

Q&A

What is YDR271C and what is its functional role in yeast chromatin remodeling?

YDR271C is a systematic designation for a yeast gene that appears to be studied in the context of chromatin remodeling complexes. Based on the research data, YDR271C is examined alongside key components of the SWR1 complex, particularly in relation to Arp6 and Swr1 proteins . These components play crucial roles in the incorporation of the histone variant Htz1 (equivalent to H2A.Z in higher eukaryotes) into chromatin.

The functional significance of YDR271C can be understood through its association with ribosomal protein genes and other genomic loci. Research indicates that the SWR1 complex, which may include or interact with YDR271C, is involved in regulating gene expression patterns, particularly at specific chromosomal locations as demonstrated by ChIP analyses .

How should researchers design ChIP experiments using YDR271C antibodies?

When designing ChIP experiments with YDR271C antibodies, researchers should follow these methodological guidelines:

  • Crosslinking optimization: Use 1% formaldehyde for 10-15 minutes as a starting point, but optimize based on the strength of YDR271C-DNA interactions.

  • Include appropriate controls: Use wild-type, ydrc271c deletion mutants, and no-antibody controls to validate specificity.

  • Quantification methods: Implement real-time quantitative PCR for analyzing immunoprecipitated DNA, similar to the protocol used for Htz1 ChIP in the research data .

  • Experimental replication: Conduct at least three independent experiments to establish statistical significance, as demonstrated in the published protocols .

  • Data analysis: Report results as percentage of input DNA obtained by ChIP, presenting mean values with standard deviations across replicates .

How can researchers validate the specificity of YDR271C antibodies?

Thorough validation of YDR271C antibody specificity requires multiple complementary approaches:

  • Genetic validation: Test antibody reactivity in wild-type versus ydrc271c deletion strains to confirm signal specificity.

  • Tagged protein controls: Compare results using anti-YDR271C antibody with those obtained using epitope-tagged versions (e.g., FLAG-tagged YDR271C), similar to the approach used for Arp6-FLAG and Swr1-FLAG in the literature .

  • Binding pattern analysis: Compare YDR271C binding patterns with those of known interacting partners or complex members to verify biological relevance.

  • Cross-reactivity assessment: Perform western blot analysis across multiple yeast strains to ensure the antibody does not detect unrelated proteins.

  • Peptide competition: Pre-incubate the antibody with immunizing peptide to confirm epitope-specific binding.

What is the optimal protocol for detecting YDR271C localization on chromosomes?

For optimal detection of YDR271C chromosomal localization, researchers should adopt a comprehensive approach:

  • ChIP-seq methodology:

    • Fragment chromatin to 200-500bp through optimized sonication

    • Immunoprecipitate with validated YDR271C antibody

    • Prepare sequencing libraries with appropriate controls

    • Apply rigorous bioinformatic analysis to identify binding sites

  • Visualization approach:

    • Generate binding profiles across chromosomes, similar to the visualization used for Arp6 and Swr1 localization

    • Compare binding at specific genomic features (telomeres, centromeres, ribosomal protein genes)

    • Create scatterplots to assess correlation with binding of other complex members

  • Validation of key sites:

    • Confirm ChIP-seq peaks using targeted ChIP-qPCR

    • Analyze binding at functionally relevant loci, such as the GAL1, SWR1, and ribosomal protein gene promoters

  • Data representation:

    • Present binding as log2 ratios compared to background

    • Include statistical measures (p-values) for significant binding sites

How do deletion mutants affect YDR271C binding patterns and gene expression?

Deletion mutant analysis provides critical insights into YDR271C function:

  • Impact on binding patterns:

    • Research demonstrates that deletion of SWR1 complex components affects the binding patterns of associated proteins. For example, Arp6 binding patterns change in swr1Δ cells .

    • Similar approaches could reveal how other mutations affect YDR271C localization.

  • Effects on gene expression:

    • Quantitative analysis of specific genes in deletion mutants can reveal functional relationships.

    • Research shows differential expression of genes like RDS1 (YCR106W) and UBX3 (YDL091C) in arp6- and htz1-deletion mutants .

    • Expression analysis should be normalized to a housekeeping gene like ACT1 .

  • Experimental approach:

    • Use real-time quantitative RT-PCR to measure transcript levels

    • Express results as relative amount compared to control genes

    • Present data as mean ± SD from multiple independent experiments

Table 1: Example Gene Expression Changes in Deletion Mutants

GeneWild-Type (Relative to ACT1)arp6Δ (Relative to ACT1)htz1Δ (Relative to ACT1)
RDS11.02.56.0
UBX31.04.08.0

Note: Values approximated from Figure S8 in the research data

What are the best practices for analyzing ChIP-seq data for YDR271C?

Robust ChIP-seq analysis for YDR271C should follow these best practices:

  • Quality control measures:

    • Assess sequencing depth and library quality

    • Calculate enrichment metrics (fraction of reads in peaks)

    • Evaluate replicate consistency using correlation analyses

  • Peak calling strategies:

    • Use multiple peak callers to increase confidence in identified binding sites

    • Apply appropriate parameters based on expected binding patterns

    • Implement stringent statistical thresholds (p-value < 0.025 as used in the research)

  • Comparative analysis:

    • Generate scatterplots comparing binding log2 ratios between different factors or conditions

    • Calculate correlation coefficients to quantify relationships between binding patterns

    • Identify regions with differential binding across experimental conditions

  • Functional annotation:

    • Categorize binding sites based on genomic features

    • Analyze enrichment at specific gene categories (e.g., ribosomal protein genes)

    • Integrate with expression data to identify functional relationships

How should researchers investigate YDR271C's role in protein complexes?

Investigating YDR271C's role in protein complexes requires sophisticated approaches:

  • Co-immunoprecipitation studies:

    • Use YDR271C antibody to pull down associated proteins

    • Identify interacting partners through mass spectrometry

    • Confirm interactions with reciprocal co-IPs using antibodies against suspected partners

  • Functional dependency analysis:

    • Assess how complex assembly changes in deletion mutants

    • Determine if YDR271C localization depends on other complex members, similar to how Arp6 localization changes in swr1 cells

    • Investigate whether YDR271C affects the recruitment of other factors to chromatin

  • Structural studies:

    • Analyze the integration of YDR271C within larger complexes

    • Determine spatial relationships with other complex components

    • Identify domains critical for complex assembly and function

  • ChIP-reChIP approaches:

    • Use sequential ChIP to determine co-occupancy of YDR271C with other factors at specific genomic locations

    • Quantify co-localization frequency across the genome

What are the most reliable methodologies for quantifying YDR271C-associated chromatin changes?

For reliable quantification of YDR271C-associated chromatin changes:

  • Histone variant incorporation analysis:

    • Measure Htz1 incorporation at specific loci using ChIP-qPCR

    • Compare incorporation in wild-type versus ydrc271c mutants

    • Present data as percentage of input DNA obtained by ChIP

  • Nucleosome positioning assays:

    • Use MNase-seq to map nucleosome positions in wild-type and mutant strains

    • Analyze changes in nucleosome occupancy and positioning

    • Correlate with YDR271C binding sites

  • Chromatin accessibility measurements:

    • Implement ATAC-seq to assess changes in chromatin accessibility

    • Compare accessibility profiles between wild-type and mutant strains

    • Identify regions where YDR271C activity affects chromatin structure

  • Gene association studies:

    • Investigate association of specific genes with nuclear pore complex in presence/absence of YDR271C

    • Use ChIP with antibodies against nuclear pore complex proteins

    • Quantify and present data relative to control conditions

How can computational approaches improve YDR271C antibody design and implementation?

Modern computational approaches offer significant advantages for YDR271C antibody design:

  • AI-driven antibody generation:

    • Implement deep learning models trained on antibody-antigen interactions

    • Generate diverse antibody sequences with potential binding to YDR271C

    • Screen candidates computationally before experimental validation

  • Zero-shot antibody design:

    • Apply generative AI approaches that can design antibodies without prior optimization

    • Create antibodies with high sequence diversity and low homology to existing antibodies

    • Leverage "Naturalness" metrics to ensure developability and low immunogenicity

  • High-throughput screening integration:

    • Combine computational design with experimental screening methods

    • Test large libraries of candidate antibodies (hundreds of thousands) as demonstrated for other targets

    • Validate binding using surface plasmon resonance (SPR) or similar techniques

  • Structural prediction:

    • Use AlphaFold2 or similar tools to predict YDR271C structure

    • Design antibodies targeting specific epitopes with optimal accessibility

    • Model antibody-antigen complexes to optimize binding interactions

How should researchers address inconsistent results with YDR271C antibodies?

When facing inconsistent results with YDR271C antibodies, implement this systematic approach:

  • Antibody validation reassessment:

    • Confirm antibody specificity using genetic controls (ydrc271c strains)

    • Test multiple antibody lots or sources to identify batch variation

    • Validate epitope integrity and recognition in different experimental conditions

  • Experimental standardization:

    • Control for growth conditions that may affect chromatin states (carbon source, growth phase)

    • Standardize sample preparation and extraction methods

    • Implement rigorous technical replication (minimum three independent experiments)

  • Technical optimization:

    • Adjust antibody concentration and incubation conditions

    • Optimize extraction methods for nuclear/chromatin-bound proteins

    • Incorporate appropriate blocking reagents to reduce non-specific binding

  • Biological variability considerations:

    • Account for cell cycle effects on chromatin structure

    • Consider stress responses that may alter YDR271C localization or abundance

    • Integrate time-course experiments to capture dynamic changes

What approaches can resolve contradictory findings in YDR271C binding studies?

To resolve contradictory findings in YDR271C binding studies:

  • Methodological comparison:

    • Analyze differences in ChIP protocols that might affect outcomes

    • Compare antibodies used (monoclonal vs polyclonal, different epitopes)

    • Evaluate fixation and sonication conditions that impact chromatin preparation

  • Integrative analysis:

    • Correlate YDR271C binding with other factors (e.g., comparing Arp6 and Swr1 binding patterns)

    • Examine binding in context of transcriptional activity and chromatin state

    • Create scatterplots to visualize relationships between different datasets

  • Orthogonal validation:

    • Confirm key findings using alternative techniques (CUT&RUN, DamID)

    • Implement genetic approaches to validate functional relationships

    • Perform expression analysis to connect binding with functional outcomes

  • Statistical rigor:

    • Apply appropriate statistical tests with multiple testing correction

    • Ensure sufficient biological replicates for statistical power (n≥3)

    • Report p-values for significant findings and effect sizes

How should gene expression changes be interpreted in YDR271C studies?

For proper interpretation of gene expression changes:

  • Experimental design considerations:

    • Compare wild-type, ydrc271c, and related mutants (e.g., arp6, swr1, htz1)

    • Use real-time quantitative RT-PCR with appropriate normalization controls

    • Include multiple biological replicates and report standard deviations

  • Data analysis framework:

    • Normalize to housekeeping genes (e.g., ACT1) for relative expression

    • Calculate fold changes relative to wild-type conditions

    • Apply appropriate statistical tests to determine significance

  • Functional interpretation:

    • Correlate expression changes with YDR271C binding patterns

    • Group affected genes by functional categories or pathways

    • Compare with known targets of related factors (e.g., genes affected in arp6 or htz1 mutants)

  • Mechanistic connections:

    • Analyze changes in histone variant incorporation at differentially expressed genes

    • Determine if gene positioning (nuclear periphery vs interior) correlates with expression changes

    • Investigate relationship between chromatin accessibility and expression changes

How are AI approaches transforming antibody design for chromatin-associated proteins like YDR271C?

AI technologies are revolutionizing antibody design with particular relevance to chromatin factors:

  • Generative AI applications:

    • Zero-shot generative models can create novel antibody sequences without iterative optimization

    • Deep learning approaches trained on antibody-antigen interactions produce diverse candidates

    • Models can design antibodies with high affinity without additional maturation steps

  • Sequence-structure relationships:

    • AI models generate antibodies with "high sequence diversity" and "low sequence identity to known antibodies"

    • These antibodies "adopt variable structural conformations" while maintaining target binding

    • This approach enables creation of antibodies against challenging targets like chromatin-associated proteins

  • Developability assessment:

    • "Naturalness metric" evaluates antibody sequences for favorable developability profiles

    • This predicts properties like stability and low immunogenicity

    • Reduces the need for extensive engineering after initial design

  • High-throughput integration:

    • AI design coupled with massive experimental screening (over 400,000 variants)

    • Rapid identification of high-affinity binders using surface plasmon resonance

    • This approach could accelerate development of research-grade and therapeutic antibodies

What future research directions will advance understanding of YDR271C function?

Future research should explore these promising directions:

  • Genome-wide functional analysis:

    • Comprehensive ChIP-seq mapping of YDR271C across diverse conditions

    • Integration with nucleosome positioning and histone modification data

    • Correlation with three-dimensional genome organization

  • Mechanistic investigations:

    • Structural studies of YDR271C within chromatin remodeling complexes

    • Single-molecule approaches to observe dynamics of YDR271C activity

    • CRISPR-based screens to identify genetic interactions

  • Translational connections:

    • Identification and characterization of YDR271C homologs in higher eukaryotes

    • Investigation of disease associations of human orthologs

    • Exploration of YDR271C-related pathways as therapeutic targets

  • Technological integration:

    • Application of AI-designed antibodies to study YDR271C with improved specificity

    • Implementation of CRISPR-based genomic editing to create precise mutations

    • Development of optogenetic tools to control YDR271C activity with spatiotemporal precision

How can multi-omics approaches enhance YDR271C functional studies?

Integrative multi-omics strategies offer powerful insights into YDR271C function:

  • Integrated genomics approach:

    • Combine ChIP-seq, RNA-seq, and ATAC-seq in wild-type and mutant backgrounds

    • Correlate YDR271C binding with expression changes and chromatin accessibility

    • Identify direct versus indirect effects through temporal studies

  • Proteomics integration:

    • Map YDR271C protein interactions through IP-mass spectrometry

    • Characterize post-translational modifications affecting YDR271C function

    • Quantify complex composition changes in different conditions

  • Metabolomics connections:

    • Explore links between YDR271C activity and cellular metabolism

    • Investigate effects on ribosomal protein genes and translation machinery

    • Determine metabolic consequences of altered chromatin states

  • Computational integration:

    • Develop network models incorporating multiple data types

    • Apply machine learning to predict YDR271C binding sites and functional outcomes

    • Create visualization tools for integrated multi-omics data interpretation

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.